Press Releases – VIVO Cannabis

March 28, 2023

VIVO Cannabis Announces Fourth Quarter 2022 Results

Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreement with MediPharm Labs Inc. whereby MediPharm […]

March 24, 2023

VIVO Cannabis Obtains Final Court Order Approving Its Plan of Arrangement with MediPharm

Toronto, Ontario–(Newsfile Corp. – March 24, 2023) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (“VIVO“) is pleased to announce that it has obtained a final court order (the “Final Order“) from the Ontario Superior Court of Justice (Commercial List) approving the previously announced plan of arrangement (the “Arrangement“) with MediPharm Labs Corp. (“MediPharm“) under […]

March 21, 2023

VIVO Cannabis Announces Approval of Proposed Arrangement at Special Meeting of Shareholders

Toronto, Ontario–(Newsfile Corp. – March 21, 2023) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (“VIVO“) is pleased to announce that, at the special meeting of the shareholders of VIVO (the “Shareholders“) held today (the “Meeting“), the Shareholders approved (i) a special resolution (the “Arrangement Resolution“) authorizing a plan of arrangement under section 192 of […]

December 22, 2022

MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets and channels to create a pro-forma Combined Company with over $50M in annualized revenue, based on Q3 2022.(1)(2)(3)(4) Pro-forma Combined Company is expected to have positive EBITDA(5) synergies of between $7M to $9M on an […]

November 14, 2022

VIVO Cannabis Announces Third Quarter 2022 Results

Net revenue for Q3 2022 was $6.2 million, a 19% increase from prior quarter International sales reach $2.5 million Beacon Medical continues to be the leading medical cannabis flower brand in Australia The Company entered into a third supplement to the indenture for its debentures to extend their maturity to 2024 Subsequent to the quarter-end, […]

October 3, 2022

VIVO Cannabis Announces Third Supplemental Debenture Indenture

Toronto, Ontario–(Newsfile Corp. – October 3, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) is pleased to announce that, further to the Company’s news release of September 19, 2022, the Company has entered into a third supplemental debenture indenture dated September 29, 2022 (the “Supplemental Indenture“) with TSX Trust Company […]

September 19, 2022

VIVO Cannabis Announces Agreement to Amend Outstanding Debentures

Toronto, Ontario–(Newsfile Corp. – September 19, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) has entered into an agreement dated September 15, 2022 with the majority beneficial owner of its outstanding unsecured convertible debentures dated February 28, 2018 in the aggregate principal amount of $5,546,808 (collectively, the “Debentures“) to amend […]

August 15, 2022

VIVO Cannabis Announces Second Quarter 2022 Results

Net revenue for Q2 2022 was $5.2 million Company announced that Canna Farms received a Research Licence from Health Canada in June, 2022 Canadian Launch of Fireside™ Pink Kush and Girl Scout Cookies Full-Spectrum 510 Vapes Australian sales delayed due to new regulatory requirements Company announces cost savings workforce reductions focused on its Hope, BC […]

July 22, 2022

VIVO Cannabis Announces Canna Farms Granted Research Licence by Health Canada

Toronto, Ontario–(Newsfile Corp. – July 22, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO“ or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”), ABcann Medicinals Inc., today announced that Canna Farms has […]

July 2, 2022

VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors

Toronto, Ontario–(Newsfile Corp. – July 2, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the "Meeting"). As announced this morning, at the Meeting, shareholders […]